A federal judge overseeing the first federal trial against opioid defendants said he would reach out to the U.S. Department of Justice to determine whether to disqualify defense attorney Carole Rendon and her firm, Baker & Hostetler, from the case.

U.S. District Judge Dan Polster, who is overseeing more than 1,500 lawsuits by cities and counties across the country, heard testimony in court Wednesday from Rendon and three public officials about her former job as U.S. Attorney for the Northern District of Northern District of Ohio, during which she headed an opioid task force. Rendon, who is a partner in Cleveland, represents Endo Pharmaceuticals Inc., one of the opioid manufacturers in the case.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]